Philips introduces fully integrated echocardiography experience, bringing together new transducer technology, AI-driven automated measurements and remote access at EuroEcho 2021
09 Dicembre 2021 - 10:00AM
Philips introduces fully integrated echocardiography experience,
bringing together new transducer technology, AI-driven automated
measurements and remote access at EuroEcho 2021
December 9, 2021
- Philips’ next-generation nSIGHT Plus imaging
architecture and new X5-1c Transthoracic Transducer drive
breakthrough cardiac imaging performance
- Debut of AI-enhanced Auto Measure application helps reduce echo
quantification time, improving patient and staff experience
- New remote access with diagnostic confidence on Collaboration
Live solution extends the reach and efficiency of ultrasound
teams
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG,
AEX: PHIA), a global leader in health technology, today expanded
its ultrasound portfolio with new robust imaging tools and features
for Cardiology to increase diagnostic confidence and workflow
efficiency. During its participation in the EuroEcho 2021 Virtual
Congress, taking place December 9-11, Philips will showcase how its
cardiac ultrasound solutions support cardiology patients and
clinicians, from early detection, diagnosis and treatment, through
ongoing assessment and long-term follow-up.
Integrated systems and informatics enable efficiency and
diagnostic confidence Philips brings together the latest
release of the EPIQ CVx and Affiniti CVx ultrasound platforms,
automated analysis, Collaboration Live remote diagnosis and
Cardiovascular Workspace – IntelliSpace Cardiovascular – end-to-end
workflow, for a fully integrated experience in echocardiography.
Advanced technology is helping to foster first-time-right diagnosis
and timely treatment. Philips nSIGHT Plus is a proprietary
imaging architecture that touches all aspects of image acquisition
and processing, creating images with optimal resolution down to the
pixel level, in contrast with conventional systems that form the
image line by line. In addition, the new Philips X5-1c transducer
facilitates easier access to imaging windows between the ribs.
Clinician feedback showed that diagnostic confidence in 3D left
ventricular function quantification was improved in 80% of patients
undergoing transthoracic echo (TTE) exams using the X5-1c
transducer [1]. Philips’ AI-enhanced Auto Measure application
delivers fast and consistent measurements in half the time of
manual methods. Using Auto Measure on Philips EPIQ CVx and Affiniti
CVx ultrasound systems can reduce the time for standard 2D echo
measurements by 51% [2]. Auto Measure AI and AutoStrain Left Atrium
(LA) and Right Ventricle (RV) are now available across the Philips
CVx portfolio.
Enabling remote access and limiting risk of COVID-19 exposure,
Philips echocardiography suite also includes Collaboration Live, an
integrated tele-ultrasound solution providing remote access to
clinical staff in real-time during exams.
“With echocardiography the first imaging modality utilized for a
greater volume of patients [3], clinicians are relying on
ultrasound to provide care more than ever before,” said Jeff Cohen,
General Manager of Ultrasound at Philips. “Cardiac imaging
workflows need to be streamlined at every step to address the
volume and complexity of cases. Philips echocardiography provides a
connected ecosystem of integrated workflow solutions for
cardiology. Combined with advanced diagnostic tools, our integrated
solutions deliver clear insights on the patient’s condition
quickly. These recent introductions also reinforce how our
ultrasound capabilities bring strong clinical value to areas
outside of echocardiography, including liver disease management, to
help improve decision support and care at each step in the patient
journey.”
“Imaging performance is the most important attribute to allow me
to be confident in my diagnosis and treatment planning,” said Dr.
Roberto Lang, Director, Noninvasive Cardiac Imaging Laboratory,
University of Chicago. During the European Society of Cardiology
virtual symposium, “Transthoracic echo like you’ve never seen
before,” Dr. Lang explains how the new X5-1c echo transducer and
AI-enhanced quantification are designed to improve clinical
confidence in everyday patient care.
Delivering better heart care with greater efficiency and
clinical confidence Philips Ultrasound System – EPIQ CVx – and
Ultrasound System – Affiniti CVx – provide a suite of
features that can help reduce exam times, from the echo lab to the
patient bedside, all while providing the confidence clinicians need
to help enhance decision-making to inform the best treatment
plan.
EuroEcho registrants are invited to join the Philips satellite
symposium, “Using the latest innovations in Echocardiography to
improve patient care,” on December 10, featuring Professors
Denisa Muraru, Teresa Lopez Fernandez, and Manuel Barreiro Perez
and hosted by Professor Bernard Cosyns.
For more information on Philips’ latest innovative technology
across its portfolio of cardiology ultrasound solutions, visit the
Philips echocardiography page.
[1] Based on Philips external testing as compared to X5-1
transducer.[2] Based on Philips external testing as compared to
manual measurement methods. [3] Reeves RA, Halpern EJ, Rao
VM. Cardiac Imaging Trends from 2010 to 2019 in the Medicare
Population. Radiology: Cardiothoracic Imaging. 2021 Sep 30;
3(5):e210156.
For further information, please contact:
Kathy O’ReillyPhilips Global Press OfficeTel.: + 1 978 221
8919E-mail: kathy.oreilly@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
well-being, and enabling better outcomes across the health
continuum – from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health
and home care. Philips generated 2020 sales of EUR 17.3 billion and
employs approximately 78,000 employees with sales and services in
more than 100 countries. News about Philips can be found at
www.philips.com/newscenter.
- Philips X5 -1c Transthoracic Transducer in use
- Philips X5 -1c Transthoracic Transducer
Grafico Azioni Koninklijke Philips NV (EU:PHIA)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Koninklijke Philips NV (EU:PHIA)
Storico
Da Apr 2023 a Apr 2024